Concepedia

Janet B. Serle

JB

Statistics

Publications

38

Citations

2.1K

H-Index

24

Active since

1983

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Aerie Pharmaceuticals (United States)

Mount Sinai Hospital

New York State Department of Health

National Center for Environmental Health

Janet B. Serle is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, ocular pharmacology, and ophthalmology.

ORCID

Publications per year

1983–2022

38

Publications

38

Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2)

Janet B. Serle, L. Jay Katz, Eugene McLaurin et al. · American Journal of Ophthalmology · 2017 · 265 citations · Full text

, , +13

Effect of 0.04% AR-13324, a ROCK, and Norepinephrine Transporter Inhibitor, on Aqueous Humor Dynamics in Normotensive Monkey Eyes

Rongfang Wang, Jennifer E. Williamson, Casey Kopczynski et al. · Journal of Glaucoma · 2013 · 124 citations

, , +16

Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2)

Malik Y. Kahook, Janet B. Serle, Francis S. Mah et al. · American Journal of Ophthalmology · 2019 · 115 citations

, , +13

Maintained Reduction of Intraocular Pressure by Prostaglandin F2α-1-Isopropyl Ester Applied in Multiple Doses in Ocular Hypertensive and Glaucoma Patients

Carl B. Camras, Earlene C. Siebold, Jacqueline S. Lustgarten et al. · Ophthalmology · 1989 · 105 citations

, , +9

Once-Daily Netarsudil Versus Twice-Daily Timolol in Patients With Elevated Intraocular Pressure: The Randomized Phase 3 ROCKET-4 Study

Albert S Khouri, Janet B. Serle, Jason Bacharach et al. · American Journal of Ophthalmology · 2019 · 105 citations

, , +17

1–5 of 38